New research presented identifies interferon-induced transmembrane protein 3 (IFITM3) as a critical regulator of immunotherapy sensitivity in small cell lung cancer (SCLC), offering a promising new ...

As of July 1, the insurer changed its policy related to five drugs given at infusion centers in Connecticut. To serve Aetna ...

In the quest to address infertility, Cornell University researchers have developed a groundbreaking device that could ...

Opening an IV therapy clinic requires more than a basic understanding of infusion protocols. The right equipment and ...